Ipamorelin
Selective GH Secretagogue
A selective growth hormone secretagogue and ghrelin mimetic that stimulates GH release.
Overview
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue. It acts as a ghrelin mimetic, binding to the GHS-R1a receptor to stimulate GH release. Research has investigated its selectivity for GH release without significant effects on cortisol or prolactin.
Research Information
Research on Ipamorelin has demonstrated its ability to produce clean GH pulses without the cortisol and prolactin elevation seen with other GHSs. Studies have investigated its effects on GH-IGF-1 axis, body composition, and bone density. Research has also explored its potential synergistic effects when combined with GHRH analogues.
Research Dosage Reference
Research protocols typically use doses of 200–300 mcg per injection. Standard vials contain 5mg lyophilized powder. All dosing information is for research reference only.
Related Research
Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.